Abstract
Abstract A moderate and statistically significant elevation of blood pyruvate levels, determined by an enzymatic method, was found in 60 patients with various malignant neoplastic disorders as compared with 20 control subjects. Studied were 42 cases of metastatic carcinoma, including 14 in which there were hepatic metastases and 18 cases of leukemia and lymphoma. No significant statistical difference was found when the values for the patients with malignant disease were compared with those found for a group of patients with non-neoplastic liver disorders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
